The neurobiology of addiction: A neuroadaptational view relevant for diagnosis

Addiction

Volumn 101, Issue SUPPL. 1, 2006, Pages 23-30

  Koob, George F ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Addiction; Animal models; Extended amygdala; Reward; Stress

Indexed keywords

CORTICOTROPIN RELEASING FACTOR; DOPAMINE; OPIATE PEPTIDE; TRANSCRIPTION FACTOR;

ADDICTION; AMYGDALOID NUCLEUS; DRUG DEPENDENCE; INTOXICATION; NEUROBIOLOGY; NONHUMAN; ORBITAL CORTEX; PREFRONTAL CORTEX; RELAPSE; REVIEW; REWARD; STRESS; SUBSTANCE ABUSE;

ADAPTATION, PHYSIOLOGICAL; AMYGDALA; ANIMALS; BRAIN; BRAIN CHEMISTRY; DISEASE MODELS, ANIMAL; HUMANS; NEURONS; SUBSTANCE WITHDRAWAL SYNDROME; SUBSTANCE-RELATED DISORDERS; TRANSCRIPTION FACTORS;

EID: 33746870694     PISSN: 09652140     EISSN: 13600443     Source Type: Journal    
DOI: 10.1111/j.1360-0443.2006.01586.x     Document Type: Review

References (51)

1. Koob G. F., Le Moal M. Drug abuse: hedonic homeostatic dysregulation. Science 1997; 278: 52-8.
2. Shippenberg T. S., Koob G. F. Recent advances in animal models of drug addiction and alcoholism. In: Davis K. L., Charney D., Coyle J. T., Nemeroff C., editors. Neuropsychopharmacology: the fifth generation of progress. Philadelphia: Lippincott, Williams & Wilkins; 2002, p. 1381-97.
3. Koob G. F., Le Moal M. Drug addiction, dysregulation of reward, and allostasis. Neuropsychopharmacology 2001; 24: 97-129.
4. Koob G. F. Allostatic view of motivation: implications for psychopathology. In: Bevins R. A., Bardo M. T., editors. Motivational Factors in the Etiology of Drug Abuse. Series title:Nebraska Symposium on Motivation, vol. 50. Lincoln, NE: University of Nebraska Press; 2004, p. 1-18.
5. Koob G. F., Sanna P. P., Bloom F. E. Neuroscience of addiction. Neuron 1998; 21: 467-76.
6. Heimer L., Alheid G. Piecing together the puzzle of basal forebrain anatomy. In: Napier T. C., Kalivas P. W., Hanin I., editors. The Basal Forebrain: anatomy to function. Series title: Advances in Experimental Medicine and Biology, vol. 295. New York: Plenum Press; 1991, p. 1-42.
7. Markou A., Koob G. F. Post-cocaine anhedonia: an animal model of cocaine withdrawal. Neuropsychopharmacology 1991; 4: 17-26.
8. Schulteis G., Markou A., Gold L. H., Stinus L., Koob G. F. Relative sensitivity to naloxone of multiple indices of opiate withdrawal: a quantitative dose-response analysis. J Pharmacol Exp Ther 1994; 271: 1391-8.
9. Schulteis G., Markou A., Cole M., Koob G. Decreased brain reward produced by ethanol withdrawal. Proc Natl Acad Sci USA 1995; 92: 5880-4.
10. Epping-Jordan M. P., Watkins S. S., Koob G. F., Markou A. Dramatic decreases in brain reward function during nicotine withdrawal. Nature 1998; 393: 76-9.
11. Gardner E. L., Vorel S. R. Cannabinoid transmission and reward-related events. Neurobiol Dis 1998; 5: 502-33.
12. Paterson N. E., Myers C., Markou A. Effects of repeated withdrawal from continuous amphetamine administration on brain reward function in rats. Psychopharmacology 2000; 152: 440-6.
13. Parsons L. H., Justice J. B. Jr Perfusate serotonin increases extracellular dopamine in the nucleus accumbens as measured by in vivo microdialysis. Brain Res 1993; 606: 195-9.
14. Weiss F., Markou A., Lorang M. T., Koob G. F. Basal extracellular dopamine levels in the nucleus accumbens are decreased during cocaine withdrawal after unlimited-access self-administration. Brain Res 1992; 593: 314-8.
15. Stinus L., Le Moal M., Koob G. F. Nucleus accumbens and amygdala are possible substrates for the aversive stimulus effects of opiate withdrawal. Neuroscience 1990; 37: 767-73.
16. Roberts A. J., Cole M., Koob G. F. Intra-amygdala muscimol decreases operant ethanol self-administration in dependent rats. Alcohol Clin Exp Res 1996; 20: 1289-98.
17. Weiss F., Parsons L. H., Schulteis G., Hyytia P., Lorang M. T., Bloom F. E. et al. Ethanol self-administration restores withdrawal-associated deficiencies in accumbal dopamine and 5-hydroxytryptamine release in dependent rats. J Neurosci 1996; 16: 3474-85.
18. Morrisett R. A. Potentiation of N-methyl-D-aspartate receptor-dependent afterdischarges in rat dentate gyrus following in vitro ethanol withdrawal. Neurosci Lett 1994; 167: 175-8.
19. Davidson M., Shanley B., Wilce P. Increased NMDA-induced excitability during ethanol withdrawal: a behavioural and histological study. Brain Res 1995; 674: 91-6.
20. Collins A. C., Bhat R. V., Pauly J. R., Marks M. J. Modulation of nicotine receptors by chronic exposure to nicotinic agonists and antagonists. In: Bock G., Marsh J., editors. The Biology of Nicotine Dependence. Series title: Ciba Foundation Symposium, vol. 152. New York: John Wiley; 1990, p. 87-105.
21. Dani J. A., Heinemann S. Molecular and cellular aspects of nicotine abuse. Neuron 1996; 16: 905-8.
22. Rivier C., Bruhn T., Vale W. Effect of ethanol on the hypothalamic-pituitary-adrenal axis in the rat: role of corticotropin-releasing factor (CRF). J Pharmacol Exp Ther 1984; 229: 127-31.
23. Merlo-Pich E., Lorang M., Yeganeh M., Rodriguez de Fonseca F., Raber J., Koob G. F. et al. Increase of extracellular corticotropin-releasing factor-like immunoreactivity levels in the amygdala of awake rats during restraint stress and ethanol withdrawal as measured by microdialysis. J Neurosci 1995; 15: 5439-47.
24. Koob G. F., Heinrichs S. C., Menzaghi F., Pich E. M., Britton K. T. Corticotropin releasing factor, stress and behavior. Semin Neurosci 1994; 6: 221-9.
25. Rasmussen D. D., Boldt B. M., Bryant C. A., Mitton D. R., Larsen S. A., Wilkinson C. W. Chronic daily ethanol and withdrawal: 1. Long-term changes in the hypothalamo-pituitary-adrenal axis. Alcohol Clin Exp Res 2000; 24: 1836-49.
26. Olive M. F., Koenig H. N., Nannini M. A., Hodge C. W. Elevated extracellular CRF levels in the bed nucleus of the stria terminalis during ethanol withdrawal and reduction by subsequent ethanol intake. Pharmacol Biochem Behav 2002; 72: 213-20.
27. Delfs J. M., Zhu Y., Druhan J. P., Aston-Jones G. Noradrenaline in the ventral forebrain is critical for opiate withdrawal-induced aversion. Nature 2000; 403: 430-4.
28. Roy A., Pandey S. C. The decreased cellular expression of neuropeptide Y protein in rat brain structures during ethanol withdrawal after chronic ethanol exposure. Alcohol Clin Exp Res 2002; 26: 796-803.
29. Heinrichs S. C., Koob G. F. Corticotropin-releasing factor in brain: a role in activation, arousal, and affect regulation. J Pharmacol Exp Ther 2004; 311: 427-40.
30. Koob G. F., Le Moal M. Plasticity of reward neurocircuitry and the 'dark side' of drug addiction. Nat Neurosci 2005; 8: 1442-4.
31. Alheid G. F., De Olmos J. S., Beltramino C. A. Amygdala and extended amygdala. In: Paxinos G., editor. The Rat Nervous System. San Diego: Academic Press; 1995, p. 495-578.
32. McFarland K., Kalivas P. W. The circuitry mediating cocaine-induced reinstatement of drug-seeking behavior. J Neurosci 2001; 21: 8655-63.
33. Everitt B. J., Wolf M. E. Psychomotor stimulant addiction: a neural systems perspective. J Neurosci 2002; 22: 3312-20 [erratum: 22(16), 1a].
34. Weiss F., Ciccocioppo R., Parsons L. H., Katner S., Liu X., Zorrilla E. P. et al. Compulsive drug-seeking behavior and relapse: neuroadaptation, stress, and conditioning factors. In: Quinones-Jenab V., editor. The Biological Basis of Cocaine Addiction. Series title: Annals of the New York Academy of Sciences, vol. 937. New York: New York Academy of Sciences; 2001, p. 1-26.
35. Shaham Y., Shalev U., Lu L., De Wit H., Stewart J. The reinstatement model of drug relapse: history, methodology and major findings. Psychopharmacology 2003; 168: 3-20.
36. Shalev U., Grimm J. W., Shaham Y. Neurobiology of relapse to heroin and cocaine seeking: a review. Pharmacol Rev 2002; 54: 1-42.
37. Koob G. F., Le Moal M. Neurobiology of Addiction. London: Academic Press; 2006.
38. Nestler E. J. Historical review: molecular and cellular mechanisms of opiate and cocaine addiction. Trends Pharmacol Sci 2004; 25: 210-8.
39. Pandey S. C. The gene transcription factor cyclic AMP-responsive element binding protein: role in positive and negative affective states of alcohol addiction. Pharmacol Ther 2004; 104: 47-58.
40. McBride W. J., Murphy J. M., Lumeng L., Li T. K. Serotonin, dopamine and GABA involvement in alcohol drinking of selectively bred rats. Alcohol 1990; 7: 199-205.
41. Murphy J. M., Stewart R. B., Bell R. L., Badia-Elder N. E., Carr L. G., McBride W. J. et al. Phenotypic and genotypic characterization of the Indiana University rat lines selectively bred for high and low alcohol preference. Behav Genet 2002; 32: 363-88.
42. Carr L. G., Foroud T., Bice P., Gobbett T., Ivashina J., Edenberg H. et al. A quantitative trait locus for alcohol consumption in selectively bred rat lines. Alcohol Clin Exp Res 1998; 22: 884-7.
43. Koob G. F., Bartfai T., Roberts A. J. The use of molecular genetic approaches in the neuropharmacology of corticotropin-releasing factor. Int J Comp Psychol 2001; 14: 90-110.
44. Contet C., Kieffer B. L., Befort K. Mu opioid receptor: a gateway to drug addiction. Curr Opin Neurobiol 2004; 14: 370-8.
45. Gaveriaux-Ruff C., Kieffer B. L. Opioid receptor genes inactivated in mice: the highlights. Neuropeptides 2002; 36: 62-71.
46. Zhang J., Xu M. Toward a molecular understanding of psychostimulant actions using genetically engineered dopamine receptor knockout mice as model systems. J Addict Dis 2001; 20: 7-18.
47. Uhl G. R., Lin Z. The top 20 dopamine transporter mutants: structure-function relationships and cocaine actions. Eur J Pharmacol 2003; 479: 71-82.
48. Caine S. B., Negus S. S., Mello N. K., Patel S., Bristow L., Kulagowski J. et al. Role of dopamine D2-like receptors in cocaine self-administration: studies with D2 receptor mutant mice and novel D2 receptor antagonists. J Neurosci 2002; 22: 2977-88.
49. Bonson K. R., Grant S. J., Contoreggi C. S., Links J. M., Metcalfe J., Weyl H. L. et al. Neural systems and cue-induced cocaine craving. Neuropsychopharmacology 2002; 26: 376-86.
50. Breiter H. C., Aharon I., Kahneman D., Dale A., Shizgal P. Functional imaging of neural responses to expectancy and experience of monetary gains and losses. Neuron 2001; 30: 619-39.
51. Childress A. R., Mozley P. D., McElgin W., Fitzgerald J., Reivich M., O'Brien C. P. Limbic activation during cue-induced cocaine craving. Am J Psychiatry 1999; 156: 11-8.